ETD Collection

Permanent URI for this collectionhttps://wiredspace.wits.ac.za/handle/10539/104


Please note: Digitised content is made available at the best possible quality range, taking into consideration file size and the condition of the original item. These restrictions may sometimes affect the quality of the final published item. For queries regarding content of ETD collection please contact IR specialists by email : IR specialists or Tel : 011 717 4652 / 1954

Follow the link below for important information about Electronic Theses and Dissertations (ETD)

Library Guide about ETD

Browse

Search Results

Now showing 1 - 1 of 1
  • Item
    The assessment of lipid levels in type 2 diabetic patients in relation to lipid modifying therapy at the charlotte Maxeke Johannesburg academic hospital (CMJAH) diabetic clinic
    (2019) Naidoo, Sagen
    Atherosclerotic cardiovascular disease is major contributor to morbidity and mortality in diabetic patients. Strict goal-directed lipid control is associated with better cardiovascular outcomes. Aim The main aim of this study is to describe the lipid profiles of a cohort of patients with type 2 diabetes mellitus in order to highlight the quality of lipid control by correlating the type and dose of lipid-modifying therapy used with lipid levels. Method A retrospective analysis was performed on 200 type 2 diabetic patients who attended the Charlotte Maxeke Johannesburg Academic Hospital diabetic clinic in March 2017. Their lipid profiles and the type and dose of lipid-modifying therapy prescribed to them were assessed. Results Although the majority of participants [146 (73%)] were at target for total cholesterol, fewer [133 (66.5%)] were at target for triglycerides, 112 (56%) participants were at target for HDL-cholesterol, only 53 (26.5%) participants were at target for LDL-cholesterol, and very few, only 25 (12.5%) participants were at target for all four lipid parameters. Conclusion The LDL-cholesterol levels of participants on statin therapy was significantly lower in statin-treated participants than in participants not treated with statins. However higher doses of statins or the use of more potent statins is recommended in order to achieve LDL-cholesterol target in the majority of diabetic patients.